Short answer
A RET variant of uncertain significance, or VUS, means the lab does not yet know whether the variant causes disease. In most situations, relatives should not be managed as if a RET VUS were a confirmed MEN2-causing pathogenic variant. Family testing may sometimes help a genetics team gather segregation evidence, but it should be coordinated carefully and should not be confused with routine cascade testing for a known pathogenic family variant.
Why a VUS is not a family variant yet
| Situation | Common next question | Why it matters |
|---|---|---|
| RET VUS found on a panel | Is there a personal or family MEN2 pattern? | Clinical context affects how seriously to investigate. |
| Relative asks for testing | Is testing for segregation or medical decision-making? | Those are different uses. |
| VUS later changes classification | Who will receive the update? | Reclassification can change follow-up. |
When family testing might still be useful
Sometimes a genetics team uses family testing to understand whether the uncertain RET result tracks with disease in the family. That is evidence gathering, not a shortcut to call the VUS pathogenic. The family should know the purpose before anyone is tested.
What it cannot prove
A RET VUS cannot by itself prove MEN2, rule it out, or tell relatives to start surveillance on the basis of the variant alone. The report may later be reclassified, but until then the safest approach is to keep the variant in the uncertain category and lean on the family history, phenotype, and genetics team.
Questions to ask
- What exact RET variant was reported, and which lab classified it as uncertain?
- Was the result germline, tumor-only, or from a consumer raw-data interpretation?
- Does the family history include medullary thyroid cancer, pheochromocytoma, parathyroid disease, or MEN2 features?
- Who will track reclassification and decide whether relatives should be tested for evidence gathering?
When follow-up matters more
Follow-up matters more when a hereditary tumor result could change who in the family should be tested, when tumor-only and germline questions are still mixed together, or when a specialist plan should decide surveillance timing rather than a single lab result. Genetics counseling helps keep the finding tied to the actual family question.
FAQ
What makes a RET result a VUS?
It means the lab does not yet know whether the variant causes disease, so the finding is not treated like a confirmed MEN2 family variant.
Should relatives be tested automatically?
Usually no. Family testing should be guided by genetics and the reason for testing, not by the VUS alone.
Can family testing ever help with a VUS?
Sometimes yes, if a genetics team is gathering segregation evidence or trying to clarify the result, but that is different from routine cascade testing.
What if the VUS is later reclassified?
The plan can change, which is why reclassification tracking matters.
Does a RET VUS rule out MEN2?
No. It just means the variant itself is uncertain, so personal and family history still matter.
What should I ask the genetics team?
Ask whether the goal is medical decision-making or evidence gathering, who will watch for reclassification, and whether any relatives should wait for a clarified result.